Suppr超能文献

苯海拉明对特发性肌张力障碍的治疗有效。

Diphenhydramine is effective in the treatment of idiopathic dystonia.

作者信息

Truong D D, Sandroni P, van den Noort S, Matsumoto R R

机构信息

Department of Neurology, University of California, Irvine, USA.

出版信息

Arch Neurol. 1995 Apr;52(4):405-7. doi: 10.1001/archneur.1995.00540280095022.

Abstract

OBJECTIVE

To assess the effectiveness of diphenhydramine hydrochloride (Benadryl) in the treatment of patients with idiopathic truncal dystonia.

DESIGN

Before-and-after trial.

SETTING

University referral center.

PATIENTS

Five consecutive patients with idiopathic truncal dystonia who were poorly treated with conventional pharmacotherapies. No patients were withdrawn from the trial for adverse side effects.

INTERVENTIONS

Treatments with diphenhydramine hydrochloride (50 mg intravenously or up to 500 mg/kg orally). Follow-up for up to 20 months.

MAIN OUTCOME MEASURE

Dystonia evaluation.

RESULTS

Diphenhydramine therapy was associated with minimal side effects, and it was most effective in treating patients with dystonia who experienced lightning jerks. Treatment with intravenous diphenhydramine may have a predictive value on a future response to oral therapy.

CONCLUSION

Diphenhydramine should be considered a therapeutic option for idiopathic truncal dystonia with lightning jerks.

摘要

目的

评估盐酸苯海拉明(苯那君)治疗特发性躯干肌张力障碍患者的疗效。

设计

前后对照试验。

地点

大学转诊中心。

患者

连续5例接受传统药物治疗效果不佳的特发性躯干肌张力障碍患者。无患者因不良反应退出试验。

干预措施

使用盐酸苯海拉明治疗(静脉注射50毫克或口服高达500毫克/千克)。随访长达20个月。

主要观察指标

肌张力障碍评估。

结果

苯海拉明治疗副作用极小,对伴有闪电样抽搐的肌张力障碍患者疗效最佳。静脉注射苯海拉明治疗可能对未来口服治疗的反应具有预测价值。

结论

对于伴有闪电样抽搐的特发性躯干肌张力障碍,应考虑将苯海拉明作为一种治疗选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验